• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM, EUROPE; LEFT VENTRICULAR ASSIST DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM, EUROPE; LEFT VENTRICULAR ASSIST DEVICE Back to Search Results
Catalog Number 106524INT
Device Problem Partial Blockage (1065)
Patient Problems Thrombus (2101); Complaint, Ill-Defined (2331)
Event Date 10/07/2017
Event Type  Death  
Manufacturer Narrative
Fda approval for heartmate 3 lvas was received on 23 august 2017.(b)(4).Approximate age of device ¿ 9 days.The device was not explanted from the patient and therefore is not expected to be returned for evaluation.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
The patient was implanted with a left ventricular assist device (lvad) on (b)(6) 2017.It was reported that approximately 9 days after implantation, the patient experienced a low flow situation down to 0.0 l/min in the intensive care unit.The patient was hemodynamically unstable and required administration of catecholamine medications.The patient was returned to the operating room and a pump exchange was performed.During the procedure, the surgeon noted an inflow cannula obstruction by a piece of tissue.No additional information was provided.
 
Manufacturer Narrative
Device evaluation: no device-related issues were discovered during the evaluation of the returned pump.Review of the submitted system controller and lvad log files as well as the log file data retrieved from returned pump confirmed the report of low flow events down to 0 l/min; however, the evaluation of the returned pump could not determine a specific cause for the low flow situation.The evaluation did not confirm the report of an inflow cannula obstruction by a piece of tissue observed upon explant of the device and no photographs were provided by the user facility.Based on the analysis of the log file data, the pump appeared to be operating as intended.The estimated flow values remained stable in the range of approximately 4.5 l/min to 5.5 l/min since the date of implant on (b)(6) 2017.However, beginning on (b)(6) 2017 at 1:44 am, the estimated flow values dropped down to 0 l/min (below the low flow threshold of 2.5 l/min), resulting in low flow hazard alarms.The low flow hazard alarms continued for the remainder of recorded data until the driveline was disconnected at 2:10 am.When the pump was connected to the backup system controller, the low flow hazard alarms continued and the estimated flow values did not rise above 1 l/min.The pump speed remained above the low speed limit during the low flow events.The pump was returned assembled with the pump cable severed approximately 9 inches from the pump housing.The modular cable and the severed portion of the pump cable were not returned.The sealed outflow graft was returned detached from the pump outflow and the sealed outflow graft bend relief was returned disengaged from the graft attachment.The cuff lock was retracted and the apical cuff was not returned.Upon disassembly of the returned device, visual inspection of the smooth and textured blood-contacting surfaces revealed a small amount of post-explant blood in the inflow cannula, outflow graft, rotor well, and one of the rotor vanes.The evaluation found no evidence of any developed depositions or thrombus formations.Visual inspection of the pump rotor and rotor well did not reveal any surface scratches or defects.Examination of the returned portion of the pump cable found it to be unremarkable.The pump was cleaned, reassembled, and operated on a mock circulatory loop.The device functioned as intended and in accordance with manufacturing specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM, EUROPE
Type of Device
LEFT VENTRICULAR ASSIST DEVICE
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6101 stoneridge dr.
pleasanton, CA 94588
7818528390
MDR Report Key6998670
MDR Text Key90935256
Report Number2916596-2017-02579
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeAU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2020
Device Catalogue Number106524INT
Other Device ID NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/13/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/08/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/17/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Life Threatening; Required Intervention;
-
-